1. Home
  2. KYTX vs YSXT Comparison

KYTX vs YSXT Comparison

Compare KYTX & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • YSXT
  • Stock Information
  • Founded
  • KYTX 2018
  • YSXT 2011
  • Country
  • KYTX United States
  • YSXT China
  • Employees
  • KYTX N/A
  • YSXT N/A
  • Industry
  • KYTX
  • YSXT Automotive Aftermarket
  • Sector
  • KYTX
  • YSXT Consumer Discretionary
  • Exchange
  • KYTX NYSE
  • YSXT Nasdaq
  • Market Cap
  • KYTX 92.1M
  • YSXT 79.2M
  • IPO Year
  • KYTX 2024
  • YSXT 2024
  • Fundamental
  • Price
  • KYTX $2.11
  • YSXT $4.60
  • Analyst Decision
  • KYTX Buy
  • YSXT
  • Analyst Count
  • KYTX 5
  • YSXT 0
  • Target Price
  • KYTX $18.80
  • YSXT N/A
  • AVG Volume (30 Days)
  • KYTX 205.0K
  • YSXT 60.7K
  • Earning Date
  • KYTX 05-16-2025
  • YSXT 02-24-2025
  • Dividend Yield
  • KYTX N/A
  • YSXT N/A
  • EPS Growth
  • KYTX N/A
  • YSXT N/A
  • EPS
  • KYTX N/A
  • YSXT 0.18
  • Revenue
  • KYTX N/A
  • YSXT $66,143,276.00
  • Revenue This Year
  • KYTX N/A
  • YSXT N/A
  • Revenue Next Year
  • KYTX N/A
  • YSXT N/A
  • P/E Ratio
  • KYTX N/A
  • YSXT $25.17
  • Revenue Growth
  • KYTX N/A
  • YSXT 21.23
  • 52 Week Low
  • KYTX $1.78
  • YSXT $2.06
  • 52 Week High
  • KYTX $17.55
  • YSXT $6.27
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 48.82
  • YSXT N/A
  • Support Level
  • KYTX $1.92
  • YSXT N/A
  • Resistance Level
  • KYTX $2.38
  • YSXT N/A
  • Average True Range (ATR)
  • KYTX 0.17
  • YSXT 0.00
  • MACD
  • KYTX 0.02
  • YSXT 0.00
  • Stochastic Oscillator
  • KYTX 41.30
  • YSXT 0.00

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: